Cholewiński Witold

Dr. Cholewiński Witold


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Reports of Practical Oncology and Radiotherapy
Verified
Journal Article
Closed access
APAgata Pietrzak
Agata Pietrzak
JKJoanna Kaźmierska
Joanna Kaźmierska
AMAndrzej Marszałek
Andrzej Marszałek
PGPaweł Golusiński
Paweł Golusiński
AHAleksandra Heydrych
Aleksandra Heydrych
CWCholewiński Witold
Cholewiński Witold
Aim: To evaluate whether the sequential dual-time-point fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (DTP 18F-FDG PET/CT) study improves the differential diagnosis in the larynx. Background: In some cases, the clinical and metabolic similarity of laryngitis and larynx cancer make differential diagnostics difficult when performing standard 18F-FDG PET/CT examinations; therefore, an additional study protocol performance seems to be of reasonable value. Materials and methods: 90 patients (mean age: 61 +/- 11 years, range: 41-84 years): 23 women (mean age: 63 +/- 10 years, range: 51-84 years) and 67 men (mean age: 61 +/- 11 years, range: 41-80 years) underwent delayed 18F-FDG PET/CT examinations at 60 and 90 min post intravenous injection (p.i.) of the radio-pharmaceutical 18F-FDG. We compared the metabolic activity of 90 structures divided into following groups: normal larynx (30 patients), laryngitis (30 lesions) and larynx cancer (30 tumors) with maximal and mean standardized uptake value (SUVmax, SUVmean) and the retention index (RI-SUVmax). We used the receiver operating characteristics (ROC) curve to evaluate the SUVmax cut-off values. Results: The SUVmax cut-off value at 60 and 90 min p.i. of 2.3 (sensitivity/specificity: 96.4%/100%) and 2.4 (94.2%/100%), respectively, distinguished normal and abnormal metabolic activity in the larynx. When laryngitis and tumors were compared, the SUVmax cut-off values obtained after initial and delayed imaging were 3.6 (87.5%/52.0%) and 6.1 (58.3%/84%), respectively. The RI-SUVmax of 1.3% (71.4%/88.1%) suggested abnormality, while RI-SUVmax of 6.6%, malignant etiology (75.0%/80.0%). Conclusions: In this study, the sequential DTP scanning protocol improved the sensitivity and specificity of the PET/CT method in terms of differential diagnosis within the larynx. (C) 2020 Greater Poland Cancer Centre. Published by Elsevier B.V. All rights reserved.

17 October 2020 in Diagnostics
Verified
Journal Article
Open access
PDF file
APAgata Pietrzak
Agata Pietrzak
AMAndrzej Marszałek
Andrzej Marszałek
MPMalgorzata Paterska
Malgorzata Paterska
PGPaweł Golusiński
Paweł Golusiński
JNJulitta Narozna
Julitta Narozna
CWCholewiński Witold
Cholewiński Witold
One of the most critical elements in the palatine tonsils (PT) patients’ management is to distinguish chronic tonsillitis and malignant tumor. The single-time-point (STP) 2-deoxy-2-[18 F]fluoro-D-glucose positron emission tomography/computed tomography (18 F-FDG PET/CT) examination offers the most significant sensitivity and specificity in the head and neck (H&N) region evaluation among commonly used methods of imaging. However, introducing dual-time-point (DTP) scanning might improve the specificity and sensitivity of the technique, limited by the 18 F-FDG non-tumor-specific patterns, especially when comparing different metabolic parameters. The study aims to compare several surrogates of the maximal standardized uptake value (SUVmax), obtained in 36 subjects, divided into confirmed by pathologic study PT cancer and tonsillitis in patients who underwent DTP 18 F-FDG PET/CT scanning. In this study, we observed the increased sensitivity and the specificity of the DTP 18 F-FDG PET/CT when compared with the standard PET/CT protocol. It could be concluded that DTP 18 F-FDG PET/CT improves the PT cancer and chronic tonsillitis differential diagnosis.

26 July 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
APAgata Pietrzak
Agata Pietrzak
AMAndrzej Marszałek
Andrzej Marszałek
TPTomasz Piotrowski
Tomasz Piotrowski
AMAdrianna Medak
Adrianna Medak
KPKatarzyna Pietrasz
Katarzyna Pietrasz
CWCholewiński Witold
Cholewiński Witold
According to the international societies’ recommendations, the 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography ([18F]FDG PET/CT) technique should not be used as the method of choice in brain tumour diagnosis. Therefore, the brain region can be omitted during standard [18F]FDG PET/CT scanning. We performed comprehensive literature research and analysed results from 14,222 brain and torso [18F]FDG PET/CT studies collected in 2010–2020. We found 131 clinically silent primary and metastatic brain tumours and 24 benign lesions. We concluded that the brain and torso [18F]FDG PET/CT study provides valuable data that may support therapeutic management by detecting clinically silent primary and metastatic brain tumours.